(AQST) – Analyst Ratings
-
Piper Sandler Starts Aquestive Therapeutics (AQST) at Overweight, 'he risk/reward profile associated with AQST shares is attractive'
-
Raymond James Starts Aquestive Therapeutics (AQST) at Outperform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AQST Stock Lookup